Member Info for dallo

LWHL

From potential death today or tomorrow to life and prospects of a great recovery in a red hot industry is ,for me with so much at stake, the turnaround of the ages

No suspension of shares

AR will be released today or tomorrow.

2022 results are irrelevant as this year is key with the forecast revenues of $9m looking very achievable and could be bettered.

Warrants now look attainable and with Tarana order secure funding for the rest of the year.

Fantastic news

Well

That is a turnaround for the ages

Great news from Tarana .

Ethernity waiting for this contract before releasing AR.

We are still alive and kicking.

I am wondering why the SP hasn't crash today given the annual results deadline of tomorrow where failure to issue will lead to a suspension of the shares from AIM .

Is it possible that Ethernity will issue the AR today or tomorrow.

If so great , but why this continual torture for us long suffering shareholders?

I think tomorrow's RNS will be the one that closes the chapter on this sorry investment for us all.

A Semiconductor company in a red hot market space biting the dust is a testament to the utter incompetence of every one involved in Ethernity.

They should be utterly ashamed of themselves and the damage they have done to investors

However I doubt they give a damn.

JT

I still think Ethernity will be bought out if they have faltered badly but at a price we may or may not be happy with.

Anything above 5p may do it if the alternative is liquidation..ouch

Jt

You are quite correct but Bergen could get a derogation from the Stock Exchange

See Teddy Sagi in Kape Technology who built up a stake of 70% and didn't have to bid.

Having said that he did eventually and bought the company out recently for a good price but shareholders still made a lot of money.

Under Stock Exchange rules where there is a collapse in the SP and material uncertainty regarding the going concern as well the possible late publication of the 2022 Annual Accounts , the Directors and Nomad must issue a RNS immediately to clarify the situation.

This RNS will, imho , be issued tomorrow.

There could be several reasons for the sharp falls in the SP including the loss of the Asian contract , the refusal of the Auditors and non executive Directors to sign off on the going concern issue particularly given the unlikely prospect of further market funding in light of the collapsed SP , the basket case Bergen being forced sellers at any price or a benign albeit unlikely scenario where some shareholders have decided in panic to offload ant any price.

Take your pick but I suspect we will know our fate in the morning.

It is an appalling vista for loyal longterm investors who believed in the company and its management who have betrayed our trust if the worst case scenario is to unfold tomorrow.

The sad thing is if the market cap drops to say £500k ( I can't believe I am writing this) then Bergen will own c75% /80% of the company and sell it for its tax losses patents , IP et al

What a joke and a catastrophe.

For clarification purposes in respect of the going concern issue, the Auditors, based on the Directors representations, must be assured that Ethernity can meet its ongoing liabilities from operating cash flows, borrowings or additional share issues including in Ethernity's case warrants over the 12 months or more from the date the Directors sign the audited accounts.

If the Directors , having authorised 2 market placings since the the 2022 year end, had any concerns over the going concern of the company they would be deemed to have committed a fraud which I don't think any director in Ethernity would ever do in a million years.

However the warrants must be an important ingredient in their analysis of the going concern so hopefully they are confident that the warrants will indeed be exercised.

Jen

I agree with your comments on Uncle Tim but this time round , the Alora pharma group is running the show and don't appear to be an operation that wants any delays given its record of getting a number of its own drug through the FDA and commercialisation.

Immupharma is the decidedly junior partner in this arrangement and Art Deas, not McCarthy, is running the show now

Uncle Tim has one job now and that is to negotiate the Rest of the World rights to Lupuzor and do deals on CIPD .

I don't expect Immupharma to be an independent company by the year end and if it can do these transactions in the next few months, shareholders could be well rewarded imho.

Significant two way trading with volume building at the moment

The question is will the SP break higher today as selling absorbed or is there is there more sellers out there.

Strange price action following the RNS...nothing in Immupharma is ever straightforward.

Probably need news on trial start date, trial funding and , hopefully, Rest of World deal on Lupuzor to get is moving higher.

After Bergens call on the 22 May , it was issued with c6.7m shares or c4.9 % of the enlarged share capital of 136m shares.

Accordingly it has sold at least 2.7million shares since then to get below 3% and perhaps a lot more if its % holding is less than 3%.

That's a lot of shares in a totally moribund market with no buyers imho.

I don't know how Bergen did it but it did.

How did Bergen clear millions of shares in the past few weeks with no volume or buyers.

Have Ethernity found its White Knight at last ?

Interestingly Sondrel released its 2022 AR on the 1st June .

Sondrel's 2022 revenues were £17.5m , losses of £3.4m and now has a market cap of c£68m .

If Ethernity can produce revenues of c $9m this year and say $15m in 2024, then surely our market cap of £3.5m looks much too low in comparison.

Jt

If Ethernity decide to delist then the SP will crash to near zero and in effect Bergen will have 60/80% of the company and will try to sell it .

More likely liquidation than delisting but still a long way off either scenario in my view.

Unnecessary gloomy discussions here and let's wait and see how what the coming weeks bring.

01234

Absolutely the maddest idea yet...delist and instantly you lose everything or if not immediately then over a short period of time in a private company in Israel.

Even if Ethernity delist they still have to deal with Bergen not to mention getting the support of major shareholders at an EGM...turkeys voting for Christmas and all that.

Delisting is the equivalent of blowing your brains out because you have a bad headache.

Red hot Semiconductor space..I should say.

Joe

Indeed it is but it can be turned around given the red Semiconductor space Ethernity is in with 6 US Patents and some very interesting technologies and Israeli tech engineers plus existing contracts which could be expanded significantly and potentially new business on the horizon.

All is not lost yet..we just need management to step up and be smart.

That's my bull case for what it is worth.

Hope springs eternal !

Remember with the Alora Group funding the pivotal Phase 2/3 trials for c$25m in respect of Lupuzor , the attraction of the Rest of the World rights to Lupuzor to a large Pharma becomes very enticing with maybe just an initial upfront cost of c£15 m plus giving royalties , milestone payments and revenue sharing to Immupharma on successful trial results.

A very cheap / petty cash punt by a Pharma for big returns.

However I wonder whether Alora might stymie this option and do a deal on the Rest of World rights to Lupuzor on similar terms and incorporate CIPD into the mix or just take Immupharma out now with the two Tims given nice roles in the new setup.

If was Art Deas that is what I would do.